Filing Details

Accession Number:
0001415889-20-001228
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-15 20:00:16
Reporting Period:
2020-05-13
Accepted Time:
2020-05-15 20:00:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1285819 Omeros Corp OMER Pharmaceutical Preparations (2834) 911663741
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1472158 J. Thomas Cable C/O Omeros Corporation
201 Elliott Avenue West
Seattle WA 98119
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-13 5,000 $5.92 40,067 No 4 M Direct
Common Stock Disposition 2020-05-13 5,000 $14.40 35,067 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-05-13 5,000 $0.00 5,000 $5.92
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-05-27 No 4 M Direct
Footnotes
  1. Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person. The trading schedule, including sale periods and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. This transaction was executed in multiple trades at prices ranging from $13.99 to $15.15; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
  3. The options previously vested and became exercisable in equal annual installments over a three-year period, with a vesting commencement date of May 28, 2010. The options expire on May 27, 2020.